Presenters:
Lars Fruergaard Jørgensen, Novo
Nordisk President and CEO
David Moore, EVP Corporate Development
Presenter:
Marcus Schindler, EVP Research & Early
Development and chief scientific officer (CSO)
Presenters:
Camilla Sylvest, EVP Commercial Strategy and Corporate
Affairs
Doug Langa, EVP North America
Mike Doustdar, EVP
International Operations
Martin Holst Lange, EVP
Development
Presenters:
Camilla Sylvest, EVP Commercial Strategy and
Corporate Affairs
Doug Langa, EVP North America
Mike
Doustdar, EVP International Operations
Martin Holst Lange, EVP Development
Presenters:
Ludovic Helfgott, EVP Rare disease
Martin Holst Lange,
EVP Development
Presenters & panel:
Camilla Sylvest, EVP Commercial
Strategy and Corporate Affairs
Martin Holst Lange, EVP
Development
Presenters:
Maziar Mike Doustdar, EVP
International Operations
Zhou Xiaping, Christine, SVP Region China
Presenters:
Andrzej Popkowski, SVP Region SEEMEA
Emil Kongshøj Larsen, SVP Region West Europe
Presenters:
Thomas Senderovitz, SVP Data Science
Lars Fogh Iversen,
SVP R&ED Digital Science and Innovation
Presenters:
Mike Doustdar and EVP International
Operations
Doug Langa, EVP North America
Presenter:
Lars Fruergaard Jørgensen, Novo
Nordisk President and CEO
Presenters:
Henrik Wulff, EVP Product Supply, Quality
& IT
Michael Hallgren, SVP Active Pharmaceutical Ingredients
Anna Sofie Christensen
ANCX@novonordisk.com
+45
3079 5713
Daniel Bohsen
DABO@novonordisk.com
Sina Meyer
AZEY@novonordisk.com
Jacob Martin Wiborg Rode
JRDE@novonordisk.com
Mark Joseph Root
MJHR@novonordisk.com
David Heiberg Landsted
DHEL@novonordisk.com
Frederik Taylor Pitter
FPTR@novonordisk.com
Ida Melvold Gjøsund
IDMG@novonordisk.com
Investors
Share price
{{priceData.date}} {{priceData.time}}